Federal cost of a national pharmacare program. (eBook, 2017) [WorldCat.org]
skip to content
Federal cost of a national pharmacare program. Preview this item
ClosePreview this item
Checking...

Federal cost of a national pharmacare program.

Author: Carleigh Busby; Canada. Office of the Parliamentary Budget Officer.
Publisher: Ottawa : Office of the Parliamentary Budget Officer, 2017.
Edition/Format:   eBook : Document : National government publication : English
Summary:
"In September 2016, the House of Commons Standing Committee on Health asked the Parliamentary Budget Officer (PBO) to provide a cost estimate of implementing a national Pharmacare program. The Committee provided the program's framework, including the inclusive list of drugs to be covered by Pharmacare based on Quebec's formulary, eligibility requirements, co-payment levels, and eligibility requirements for  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Material Type: Document, Government publication, National government publication, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Carleigh Busby; Canada. Office of the Parliamentary Budget Officer.
OCLC Number: 1009606893
Notes: Issued also in French under title: Coût d'un programme national d'assurance-médicaments de régie fédérale.
Cover title.
"28 September 2017."
Written by: Carleigh Busby. Cf. page 3 of cover.
Description: 1 online resource (88 pages) : color charts
More information:

Abstract:

"In September 2016, the House of Commons Standing Committee on Health asked the Parliamentary Budget Officer (PBO) to provide a cost estimate of implementing a national Pharmacare program. The Committee provided the program's framework, including the inclusive list of drugs to be covered by Pharmacare based on Quebec's formulary, eligibility requirements, co-payment levels, and eligibility requirements for co-payment exemptions. This paper estimates the cost to the federal government of implementing this particular framework for Pharmacare. It incorporates PBO's assumptions of the potential savings resulting from a stronger position for drug price negotiations, consumption or behavioural responses of providing coverage, and potential changes in the drug market composition. In addition, this paper provides five-year projections of these federal costs. However, the costs associated with a single administrator of drug benefit claims when compared to multiple administrators both public and private are not considered"--Executive summary, p. 1.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.